Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Meetings, Planning and Dissemination Grant: Genetics

McGill University

$4,941.00

5th annual Symposium of the QTRN: Transgenesis : New Developments and Applications

FY 2009-10

Summary
This symposium will gather researchers developing and using genetically modified animal models for human diseases and is purposely oriented to present the most up-to-date progress and direction of the transgenic animal community. The sequencing of the human genome identified tens of thousands of genes, many of them previously unknown. However, genomic sequence alone could not explain the function of most genes. Therefore, elucidating the biological activities regulated by these genes and potential roles in diseases and health remains a challenging task. The creation of mouse and rat models of human diseases has proven to be an invaluable tool in understanding gene function, which is the focus of the symposium. The QTRN's mission is to promote academic transgenic research and its applications in biomedical research within its member institutes as well as the integration and sharing of resources between the Quebec academic and biopharmaceutical research community. Therefore the QTRN's unique expertise and resources is ideal to organize and promote this symposium. It typically hosts between 60 to 120 students, technicians, and scientists including several key opinion leaders in the field. It will be hosted for the first time by the internationally renowned Rosalind and Morris Goodman Cancer Centre (GCC) where over 300 researchers, students, postdoctoral fellows and supporting staff are committed to improve the understanding, detection and treatment of all forms of cancers. The GCC has been a pioneer in the development of new animal models with its Transgenic Core Facility established in 1991 by Dr. Michel L. Tremblay. Since then, the facility has supplied hundreds of transgenic mice for members of the GCC as well as external researchers to study different genes mostly dedicated to the understanding of cancer. Building on the expertise of the GCC a session of the symposium will be devoted to transgenic animal models in biomedical research with a focus on cancer.
Program
Meetings, Planning and Dissemination Grant: Genetics
Location
—
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
187435
Name
Chagnon Melanie
Region
Unknown; Québec
Country
Unknown; Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Meetings, Planning and Dissemination Grant: Genetics
Projecttitle
5th annual Symposium of the QTRN: Transgenesis : New Developments and Applications
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$4,941
Cihrequipment2
$0
Programname2
Meetings, Planning and Dissemination Grant: Genetics
Keyworddelim
Animal Models; Cancer; Gene Modification; Transgenesis
Abstract
This symposium will gather researchers developing and using genetically modified animal models for human diseases and is purposely oriented to present the most up-to-date progress and direction of the transgenic animal community. The sequencing of the human genome identified tens of thousands of genes, many of them previously unknown. However, genomic sequence alone could not explain the function of most genes. Therefore, elucidating the biological activities regulated by these genes and potential roles in diseases and health remains a challenging task. The creation of mouse and rat models of human diseases has proven to be an invaluable tool in understanding gene function, which is the focus of the symposium. The QTRN's mission is to promote academic transgenic research and its applications in biomedical research within its member institutes as well as the integration and sharing of resources between the Quebec academic and biopharmaceutical research community. Therefore the QTRN's unique expertise and resources is ideal to organize and promote this symposium. It typically hosts between 60 to 120 students, technicians, and scientists including several key opinion leaders in the field. It will be hosted for the first time by the internationally renowned Rosalind and Morris Goodman Cancer Centre (GCC) where over 300 researchers, students, postdoctoral fellows and supporting staff are committed to improve the understanding, detection and treatment of all forms of cancers. The GCC has been a pioneer in the development of new animal models with its Transgenic Core Facility established in 1991 by Dr. Michel L. Tremblay. Since then, the facility has supplied hundreds of transgenic mice for members of the GCC as well as external researchers to study different genes mostly dedicated to the understanding of cancer. Building on the expertise of the GCC a session of the symposium will be devoted to transgenic animal models in biomedical research with a focus on cancer.
Competitiondate
200906
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chagnon, Melanie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $4,941~ $0~